Small intestinal bacterial overgrowth and toll‐like receptor signaling in patients with non‐alcoholic fatty liver disease

The pathogenesis of non‐alcoholic fatty liver disease (NAFLD) is multifactorial. There is sparse literature on the role of small intestinal bacterial overgrowth (SIBO) and toll‐like receptor (TLR) signaling in NAFLD. The present study evaluated the relationship of SIBO with expression of TLR signaling genes in patients with NAFLD.

[1]  S. Bischoff,et al.  Expression of toll‐like receptors 1–5 but not TLR 6–10 is elevated in livers of patients with non‐alcoholic fatty liver disease , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[2]  Y. Chawla,et al.  Obesity and NAFLD: the role of bacteria and microbiota. , 2014, Clinics in liver disease.

[3]  T. Fujiwara,et al.  CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy. , 2013, World journal of hepatology.

[4]  Y. Chawla,et al.  Maturation defective myeloid dendritic cells in nonalcoholic fatty liver disease patients release inflammatory cytokines in response to endotoxin , 2013, Hepatology International.

[5]  Michael Charlton,et al.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. , 2012, Gastroenterology.

[6]  R. S. Conrad,et al.  Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human livers. , 2011, Clinical immunology.

[7]  P. Scully,et al.  Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8 , 2011, Digestive Diseases and Sciences.

[8]  Y. Chawla,et al.  Nonalcoholic fatty liver in a developing country is responsible for significant liver disease , 2010, Hepatology.

[9]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[10]  J. Kluwe,et al.  Toll-like receptors as targets in chronic liver diseases , 2009, Gut.

[11]  P. Adegboyega,et al.  Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. , 2007, Journal of hepatology.

[12]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[13]  C. Knauf,et al.  Comment on: Cani et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance: Diabetes , 2007 .

[14]  R. Dhiman,et al.  The Clinicopathological Profile of Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD) is Different from That in the West , 2007, Digestive Diseases and Sciences.

[15]  L. Romics,et al.  Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. , 2005, Alcoholism, clinical and experimental research.

[16]  M. Kaczmarek,et al.  Tissue Localization of Toll‐Like Receptors in Biopsy Specimens of Liver from Children Infected with Hepatitis C Virus , 2005, Scandinavian journal of immunology.

[17]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[18]  F.R.C.S. Mr. M. R. B. Keighley M.S.,et al.  Identification of bacteria in the bile by duodenal aspiration , 2005, World Journal of Surgery.

[19]  S. Calvano,et al.  Modulation of the Lipopolysaccharide Receptor Complex (CD14, TLR4, MD-2) and Toll-Like Receptor 2 in Systemic Inflammatory Response Syndrome-Positive Patients With and Without Infection: Relationship to Tolerance , 2003, Shock.

[20]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[21]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[22]  A. Diehl,et al.  Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[23]  R. Ulevitch,et al.  Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex , 2001, The Journal of Biological Chemistry.

[24]  I. Roberts-Thomson,et al.  The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis , 2001, Gut.

[25]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[26]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[27]  C. Wells,et al.  Relative contributions of host and microbial factors in bacterial translocation. , 1991, Archives of surgery.

[28]  M. Nāẓim,et al.  Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth. , 1989, Hepato-gastroenterology.

[29]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.